Fidson Selected to Expand Influenza Treatment Access, Pandemic Preparedness

Fidson joins manufacturers across Brazil, China, India, and others under sublicence agreements to develop, manufacture generic versions of Roche’s baloxavir marboxil through MPP’s voluntary licence, supporting diversified manufacturing capacity and